RhumbLine Advisers’s Clover Health Investments CLOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.63M | Buy |
584,459
+577,374
| +8,149% | +$1.61M | ﹤0.01% | 1993 |
|
|
2025
Q1 | $25.4K | Buy |
7,085
+3,160
| +81% | +$11.3K | ﹤0.01% | 3703 |
|
|
2024
Q4 | $12.4K | Buy |
3,925
+324
| +9% | +$1.02K | ﹤0.01% | 3857 |
|
|
2024
Q3 | $10.2K | Buy |
+3,601
| New | +$10.2K | ﹤0.01% | 3888 |
|
|
2023
Q3 | – | Sell |
-17,242
| Closed | -$15.5K | – | 4319 |
|
|
2023
Q2 | $15.5K | Sell |
17,242
-462,191
| -96% | -$415K | ﹤0.01% | 3858 |
|
|
2023
Q1 | $405K | Buy |
479,433
+16,699
| +4% | +$14.1K | ﹤0.01% | 2513 |
|
|
2022
Q4 | $430K | Buy |
462,734
+11,668
| +3% | +$10.8K | ﹤0.01% | 2535 |
|
|
2022
Q3 | $767K | Buy |
451,066
+37,600
| +9% | +$63.9K | ﹤0.01% | 2286 |
|
|
2022
Q2 | $885K | Buy |
+413,466
| New | +$885K | ﹤0.01% | 2202 |
|